Literature DB >> 1814563

Castration reduces potassium-stimulated norepinephrine release from superfused olfactory bulbs of male rats.

X B Guan1, D Dluzen.   

Abstract

In order to investigate the possible relationship among the olfactory bulb (OB), norepinephrine (NE) and gonadal steroids, we measured NE release from superfused anterior and posterior OB in intact and castrated male rats (Expt. I) as well as in castrated male rats implanted with either empty or testosterone filled silastic capsules (Expt. II). Both basal and potassium (K+ 30 mM)-stimulated release of NE was greater in posterior compared to anterior OB. All groups were responsive to the K+ stimuli showing increases in NE release. The degree of K(+)-stimulated release was significantly greater in intact compared to that of castrated rats. No differences in K(+)-stimulated release were observed between castrated and castrated plus testosterone-treated groups. These results demonstrate that castration of male rats significantly reduces OB noradrenergic responsiveness to K+ stimulation, an effect which was not restored following administration of silastic capsules containing testosterone.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1814563     DOI: 10.1016/0006-8993(91)91390-m

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  2 in total

1.  The effects of clonidine on blood pressure, catecholamine and growth hormone release in hypogonadal men is preserved and not influenced by testosterone replacement therapy.

Authors:  G Del Rio; C Carani; A Velardo; M Procopio; G Zizzo; P Savio; R Mantovani; P Marrama; E Ghigo
Journal:  J Endocrinol Invest       Date:  1996-09       Impact factor: 4.256

2.  Effect of testosterone replacement therapy on the somatotrope responsiveness to GHRH alone or combined with pyridostigmine and on sympathoadrenal activity in patients with hypogonadism.

Authors:  G Del Rio; C Carani; A Velardo; G Zizzo; M Procopio; F Coletta; P Marrama; E Ghigo
Journal:  J Endocrinol Invest       Date:  1995-10       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.